GLP-1 weight loss users cut food spending in their first 3 months, says Circana. But by the end of year one, spending is ...

Results showed patients with a BMI of 40 kg/m2 or more who used glucagon-like peptide-1 receptor agonists for at least 90 ...

Investigational once-weekly retatrutide yielded the greatest weight loss of all GLP-1 receptor agonists, up to 22.1% after 48 weeks in adults with overweight or obesity and without diabetes, according ...

January is often a time for setting health goals, with weight loss topping many New Year’s resolutions. As people explore the best path forward, they may encounter a variety of ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effi ...

McGill University researchers say their study has found GLP-1 drugs are safe and effective for treating obesity and overweight adults without diabetes. The authors say the findings support using the ...

BOSTON – A Massachusetts nutritionist has advice for anyone working on having a better diet in 2025. She says rather than restricting what you eat, focus on ways to improve your gut. Gut health has ...

Months after posting weight loss of 7.5% at 36 days for patients taking MET-097i, Metsera releases mid-stage results of just ...

Metsera's MET-097i shows 11.3% weight loss in Phase 2a trial, beating Wegovy and Zepbound at 3 months, with potential for monthly dosing and no titration requirement.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...

Obesity is a common problem in society at large, but is seen at higher rates among persons living with mental disorders. The ...